Newfound Research’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$68K Sell
418
-97
-19% -$16.4K 0.17% 91
2022
Q2
$91K Sell
515
-415
-45% -$73.9K 0.19% 58
2022
Q1
$165K Buy
930
+51
+6% +$8.68K 0.21% 26
2021
Q4
$150K Buy
879
+187
+27% +$30.6K 0.18% 50
2021
Q3
$112K Buy
692
+167
+32% +$28.5K 0.18% 42
2021
Q2
$86K Buy
525
+25
+5% +$4.14K 0.17% 63
2021
Q1
$82K Sell
500
-302
-38% -$48.9K 0.19% 34
2020
Q4
$126K Buy
802
+616
+331% +$90.9K 0.32% 41
2020
Q3
$28K Buy
+186
New +$27.5K 0.08% 95

Other funds holding JNJ

Newfound Research's JNJ Position: Q3 2022 in Review

Newfound Research reduced its Johnson & Johnson (JNJ) stake by 19% in Q3 2022, selling an estimated $16.4K and leaving 418 shares worth $68K. The position accounts for 0.17% of the portfolio, ranked #91.

Newfound Research first reported a position in JNJ in Q3 2020 and has held it in 9 quarters since. The position peaked at $165K in Q1 2022. 3,625 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.

  • Newfound Research held 418 shares of Johnson & Johnson worth $68K as of Q3 2022.
  • Newfound Research sold 97 Johnson & Johnson shares in Q3 2022, an estimated $16.4K.
  • Johnson & Johnson made up 0.17% of Newfound Research's portfolio in Q3 2022, its #91 holding.
  • Newfound Research first reported a position in Johnson & Johnson in Q3 2020 and has held it in 9 quarters since.
  • Newfound Research's Johnson & Johnson position peaked at $165K in Q1 2022.
  • 3,625 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.